Healthcare / Health Information ServicesKOSDAQ
$6900.00
-150.00 (-2.13%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $4.2B · quality 55.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$94.2B
P/E
40.5x
↑EV/EBITDA
19.9x
↑ROE
6.3%
↑Gross Margin
21.8%
↓Debt/Equity
0.08
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-7.6%
FCF CAGR
—
FCF margin
14.6%
FCF / Net income
4.63x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $72.64B · net income $2.29B · FCF $10.61B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $72.64B | $72.64B | $67.94B | $73.19B | $92.07B |
| Net Income | $2.29B | $2.29B | $1.21B | $-9.59B | $-3.19B |
| EBITDA | $4.41B | $4.41B | $3.56B | $-6.81B | $261.1M |
| EPS | 170.50 | 170.50 | 90.00 | -759.00 | -255.00 |
| Gross Margin | 21.8% | 21.8% | 17.6% | 14.0% | 18.7% |
| Operating Margin | 3.0% | 3.0% | 0.3% | -5.6% | 0.6% |
| Net Margin | 3.2% | 3.2% | 1.8% | -13.1% | -3.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.08 | 0.08 | 0.07 | 0.20 | 0.21 |
| Current Ratio | 2.06 | 2.06 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $10.61B | $10.61B | $4.20B | $-2.00B | $-5.20B |
| Returns | |||||
| ROE | 6.3% | 6.3% | 3.5% | -28.1% | -10.1% |
| Valuation | |||||
| P/E | 40.47 | 40.47 | 93.61 | — | — |
| EV/EBITDA | 19.87 | 19.87 | 29.98 | — | 949.71 |
| P/B | 2.53 | 2.53 | 3.25 | 5.04 | 7.88 |
| Growth & Yield | |||||
| Revenue Growth | 6.9% | 6.9% | -7.2% | -20.5% | — |
| EPS Growth | 89.4% | 89.4% | 111.9% | -197.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
53.1%
EPS terminal req.
$612.26
Spread vs growth
36.3%
5Y implied EPS CAGR
34.2%
EPS terminal req.
$740.83
Spread vs growth
55.3%
10Y implied EPS CAGR
21.5%
EPS terminal req.
$1193.12
Spread vs growth
68.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-23.3%
Start / end P/E
99.9x → 40.5x
EPS bridge
90.00 → 170.50
Residual
-53.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.